Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin Mamat

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Cancers|April 30, 2021
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept StudyFalco Reissig, David Bauer, Kristof Zarschler, et al.
Journal of Medicinal Chemistry|April 16, 2026
Diagnostic Twins: Exploring the Radiohybrid Concept with Iodine-123 and Lanthanum-133 for PSMA-Targeted SPECT and PET ImagingTobias Krönke, Martin Ullrich, Magdalena K Blei, et al.
Journal of Medicinal Chemistry|June 20, 2015
(18)F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1 Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging AgentFang Xie, Ralf Bergmann, Torsten Kniess, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 24, 2020
Light-Activated Carbon Monoxide Prodrugs Based on Bipyridyl Dicarbonyl Ruthenium(II) ComplexesStepan Geri, Tereza Krunclova, Olga Janouskova, et al.
Nanoscale|April 17, 2018
Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor miceNadia Licciardello, Sebastian Hunoldt, Ralf Bergmann, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Alpha-Emitting Radionuclides: Current Status and Future PerspectivesMatthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, et al.
Theranostics|November 28, 2022
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albuminFalco Reissig, Kristof Zarschler, Zbynek Novy, et al.
Inorganic Chemistry|November 6, 2025
Heavy Alkaline Earth Radiometals for Cancer Theranostics: Coordination and Radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based ChelatorsSara Franchi, Mattia Asti, Magdalena K Blei, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Cancers|April 30, 2021
Towards Targeted Alpha Therapy with Actinium-225: Chelators for Mild Condition Radiolabeling and Targeting PSMA-A Proof of Concept StudyFalco Reissig, David Bauer, Kristof Zarschler, et al.
Journal of Medicinal Chemistry|April 16, 2026
Diagnostic Twins: Exploring the Radiohybrid Concept with Iodine-123 and Lanthanum-133 for PSMA-Targeted SPECT and PET ImagingTobias Krönke, Martin Ullrich, Magdalena K Blei, et al.
Journal of Medicinal Chemistry|June 20, 2015
(18)F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1 Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging AgentFang Xie, Ralf Bergmann, Torsten Kniess, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 24, 2020
Light-Activated Carbon Monoxide Prodrugs Based on Bipyridyl Dicarbonyl Ruthenium(II) ComplexesStepan Geri, Tereza Krunclova, Olga Janouskova, et al.
Nanoscale|April 17, 2018
Biodistribution studies of ultrasmall silicon nanoparticles and carbon dots in experimental rats and tumor miceNadia Licciardello, Sebastian Hunoldt, Ralf Bergmann, et al.
Pharmaceuticals (Basel, Switzerland)|January 23, 2024
Alpha-Emitting Radionuclides: Current Status and Future PerspectivesMatthias Miederer, Martina Benešová-Schäfer, Constantin Mamat, et al.
Theranostics|November 28, 2022
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albuminFalco Reissig, Kristof Zarschler, Zbynek Novy, et al.
Inorganic Chemistry|November 6, 2025
Heavy Alkaline Earth Radiometals for Cancer Theranostics: Coordination and Radiochemistry of Radium-223 and Barium-131 with Kryptofix 22-Based ChelatorsSara Franchi, Mattia Asti, Magdalena K Blei, et al.
Pageof 5